SPYD vs XBI
SPDR Portfolio S&P 500 High Dividend ETF vs SPDR S&P Biotech ETF
- • SPYD has the lower expense ratio at 0.07% vs 0.35% for XBI.
- • SPYD pays a higher dividend yield (4.26%).
Side-by-side metrics
| Metric | SPYD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.35% |
Dividend yield Trailing 12-month yield. | 4.26% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $7.37B | $10.73B |
YTD return | 13.25% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.64 | 1.10 |
P/E ratio | 17.44 | — |
Last price | $48.11 | $164.01 |
Inception | — | — |
Issuer | State Street | State Street |
SPYD top holdings
| IRM | Iron Mountain Inc | 1.61% |
| BEN | Franklin Resources Inc | 1.56% |
| CVS | CVS Health Corp | 1.51% |
| HST | Host Hotels & Resorts Inc | 1.51% |
| EIX | Edison International | 1.47% |
| TGT | Target Corp | 1.47% |
| APA | APA Corp | 1.46% |
| VTRS | Viatris Inc | 1.45% |
| KIM | Kimco Realty Corp | 1.44% |
| SPG | Simon Property Group Inc | 1.44% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About SPYD
SPYD (SPDR Portfolio S&P 500 High Dividend ETF) is Top 80 highest-yielding S&P 500 stocks. Managed by State Street, the fund carries $7.4B in assets under management, an expense ratio of 0.07%, a dividend yield of 4.26%. Its largest holding is Iron Mountain Inc (IRM), which represents 1.6% of the portfolio. Real Estate is the fund's largest sector exposure at 27.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.